NEUROPTIS BIOTECH PATENTS

- Effect of ML7 on occular surface diseases: Europe, USA

- Effect of ML7 on adult depression: Europe

- Synthesis of ML7 molecule and formulation as a non preserved eyedrop:

   Europe, USA, Japan (pending)

- Effect of Spasfon Inj. on severe Cluster Headache Crises: Europe

- Effect of Peptide 18 (Backup of ML7) on the occular surface

  and on the inflammatory syndrome: Europe

- Treatment of an inflammation or dilatation of the tarsal gland

   of the eyelid with the non preserved ML7 eye drop unidoses